B-Cell Superantigens: Molecular and Cellular Implications

References

• White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific super antigen staphylococcal enterotoxin B: Stimulation of mature T cells and atonal deletion in neonatal mice. Cell 1989; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Herman A., Kappler J. W., Marrack P., Pullen A. M. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 1991; 9: 745–772
   PubMed Web of Science ®Google Scholar
• Irwin M. J., Gascoigne N. R. Interplay between superantigens and the immune system. J Leukoc. Biol. 1993; 54: 495–503
   PubMedGoogle Scholar
• Held W., Acha-Orbea H., MacDonald H. R., Waanders G. A. Superantigens and retroviral infection: Insights from mouse mammary tumor virus. Immunology Today 1994; 15: 184–190
   PubMedGoogle Scholar
• Blackman M. A., Woodland D. L. In vivo effects of superantigens. Life Sciences 1995; 57: 1717–1735
   PubMedGoogle Scholar
• McCormack J. E., Kappler J., Marrack P. Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc. Natl. Acad. Sci. USA 1994; 91: 2086–2090
   PubMedGoogle Scholar
• He X. W., Goronzy J., Weyand C, Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., Kotzin B. L. Selective induction of rheumatoid factors by superantigens and human helper T cells. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253: 325–329
   PubMedGoogle Scholar
• Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 1990; 17: 251–272
   PubMed Web of Science ®Google Scholar
• Abe J., Kotzin B. L., Jujo K., Melish M. E., Glode M. P., Kohsaka T., Leung D. Y. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 1992; 89: 4066–4070
   PubMed Web of Science ®Google Scholar
• Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., Kotzin B. L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253: 325–329
   PubMed Web of Science ®Google Scholar
• Inganas M. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical Fc gamma and the alternative F(ab)2 epsilon protein A interactions. Scand. J. Immunol. 1981; 13: 343–352
   PubMed Web of Science ®Google Scholar
• Endressen C. The binding of protein A of immunoglobulin G and of Fab and Fc fragments. Acta pathol. Microbiol. Immunol. Scand. (C) 1979; 87: 185–189
   Google Scholar
• Romagnani S., Giudizi M. G., Del Prete G., Maggi E., Biagiotti R., Almerigogna F., Ricci M. Demonstration on protein A of two distinct immunoglo-bulin-binding sites and their role in the mitogenic activity of Staphylococcal aureus Cowan I on human B cells. J. Immunol. 1982; 129: 596–602
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H., Fleischer B. Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J. Immunol. Meth. 1987; 105: 133–137
   PubMed Web of Science ®Google Scholar
• Goodglick L., Zevit N., Neshat M. S., Braun J. Mapping the Ig superantigen-binding site of HIV-1 gp120. J. Immunol. 1995; 155: 515–5159
   Google Scholar
• Kristiansen S. V., Pascual V., Lipsky P. E. Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. J. Immunol. 1994; 153: 2974–2984
   PubMed Web of Science ®Google Scholar
• Kozlowski L. M., Kunning S. R., Zheng Y., Wheatley L. M., Levinson A. I. Staphylococcus aureus Cowan I-induced human immunoglobin responses: Preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells. J. Clin. Immunol. 1995; 15: 145–151
   PubMedGoogle Scholar
• Berberian L., Valles-Ayoub Y., Sun N., Martinez-Maza O., Braun J. A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood 1991; 78: 175–179
   PubMed Web of Science ®Google Scholar
• Berberian L., Goodglick L., Kipps T. J., Braun J. Immunoglobulin VH3 gene products: Natural ligands for HIV gp120. Science 1993; 261: 1588–1591
   PubMed Web of Science ®Google Scholar
• Muller S., Wang H., Silverman G. J., Bramlet G., Haigwood N., Kohler H. B-cell abnormalities in AIDS: Stable and clonally-restricted antibody response in HIV-1 infection. Scand. J. Immunol. 1993; 38: 327–334
   PubMedGoogle Scholar
• Silverman G. J., Roben P., Bouvet J.-P., Sasano M. Superantigen properties of a human sialoprotein involved in gut-associated immunity. J. Clin. Invest. 1995; 96: 417–426
   PubMed Web of Science ®Google Scholar
• Patella V., Bouvet J. P., Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J. Immunol. 1993; 151: 5685–5698
   PubMed Web of Science ®Google Scholar
• Lenert P., Kroon D., Spiegelberg H., Goiub E. S., Zanetti M. Human CD4 binds immunoglobulin. Science 1990; 248: 1639–1642
   PubMedGoogle Scholar
• Langone J. J. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv. Immunol. 1982; 32: 157–252
   PubMed Web of Science ®Google Scholar
• Young W. W., Tamura Y., Wolock D. M., Fox J. W. Staphylococcal protein A binding to the Fab of mouse monoclonal antibodies. J. Immunol. 1984; 133: 3163–3166
   PubMedGoogle Scholar
• Sasano M., Burton D. R., Silverman G. J. Molecular selection of human antibodies with an unconventional bacterial B cell superantigen. J. Immunol. 1993; 151: 5822–5839
   PubMed Web of Science ®Google Scholar
• Silverman G. J., Goni F., Fernandez J., Chen P. P., Frangione B., Carson D. A. Distinct patterns of heavy chain variable region subgroup use by human monoclonal autoantibodies of different specificity. J. Exp. Med. 1988; 168: 2361–2366
   PubMed Web of Science ®Google Scholar
• Silverman G. J., Goldfien R., Mageed R. A., Jefferis R., Goni F., Frangione B., Fong S., Carson D. A. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J. Clin. Invest. 1988; 82: 469–475
   PubMedGoogle Scholar
• Sasso E. H., Silverman G. J., Mannik M. Human IgM molecules that bind staphylococcal protein A contain VHIIIH chains. J. Immunol. 1989; 142: 2778–2783
   PubMed Web of Science ®Google Scholar
• Sasso E. H., Silverman G. J., Mannik M. Human IgA and IgG F(ab)2 that bind to staphylococcal protein A belong to the VHIII subgroup. J. Immunol. 1991; 147: 1877–1883
   PubMed Web of Science ®Google Scholar
• Silverman G. J. Human antibody responses to bacterial antigens: Studies of a model conventional antigen and a proposed model B cell superantigen. Int. Rev. Immunol. 1992; 9: 57–78
   PubMedGoogle Scholar
• Hakoda M., Hayashimoto S., Yamanaka H., Terai C., Kamatani N., Kashiwazaki S. Molecular basis for the interaction between human IgM and staphylococcal protein A. Clin. Immunol. Immunopathol. 1994; 72: 394–401
   PubMedGoogle Scholar
• Ibrahim S., Kaartinen M., Seppala I., Matoso-Ferreira A., Makela O. The alternative binding site for protein A in the Fab fragment of immunoglobulins. Scand. J. Immunol. 1993; 37: 257–264
   PubMedGoogle Scholar
• Hillson J. L., Karr N. S., Oppliger I. R., Mannik M., Sasso E. H. The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J. Exp. Med. 1993; 178: 331–336
   PubMed Web of Science ®Google Scholar
• Ibrahim S., Seppala I., Makela O. V-region-mediated binding of human Ig by protein A. J. Immunol. 1993; 151: 3597–3603
   PubMedGoogle Scholar
• Randen I., Potter K. N., Li Y., Thompson K. M., Pascual V., Forre O., Natvig J. B., Capra J. D. Complementarity-determining region 2 is implicated in the binding staphylococcal protein A to human immunoglobulin VHIII variable regions. Eur. J. Immunol. 1993; 23: 2682–2686
   PubMedGoogle Scholar
• Silverman G. J. Unconventional antigen-antibody binding interactions and B cell super antigens. The Immunologist 1994; 2: 51–57
   Google Scholar
• Riechmann L., Davies J. Backbone assignment, secondary structure and Protein A binding of an isolated human antibody VH domain. J. Biomolec. NMR 1995; 6: 141–152
   PubMedGoogle Scholar
• Roben P., Salem A., Silverman G. J. VH3 antibodies bind domain D of staphylococcal protein A. J. Immunol. 1995; 154: 6437–6446
   PubMed Web of Science ®Google Scholar
• Schroeder H. W. J., Hillson J. L., Perlmutter R. M. Structure and evolution of mammalian VH families. Int. Immunol. 1990; 2: 41–50
   PubMed Web of Science ®Google Scholar
• Schroeder H. W., Jr., Mortari F., Shiokawa S., Kirkham P. M., Elgavish R. A., Bertrand F. E. III Developmental regulation of the human antibody repertoire. Ann. N. Y. Acad. Sci. 1995; 764: 242–260
   PubMed Web of Science ®Google Scholar
• Myhre E. B. Interaction of bacterial immunoglobulin receptors with sites in the Fab region. Bacterial Immunoglobulin-Binding Proteins, M. D.P. Boyle. Academic Press, Inc., San Diego, CA 1990; vol. I: 243–256
   Google Scholar
• Kirkham P. M., Mortari F., Newton J. A., Schroeder H. W.J. Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EM BO J. 1992; 11: 603–609
   PubMed Web of Science ®Google Scholar
• Malchiodi E. L., Eisenstein E., Fields B. A., Ohlendorf D. H., Schlievert P. M., Karialainen K., Mariuzza R. A. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J. Exp. Med. 1995; 182: 1833–1845
   PubMedGoogle Scholar
• Seth A., Stem L. J., Ottenhoff T. H., Engel I., Owen M. J., Lamb J. R., Klausner R. D., Wiley D. C. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 1994; 369: 324–327
   PubMed Web of Science ®Google Scholar
• Padlan E. A. Anatomy of the antibody molecule. Mol. Immunol. 1994; 31: 169–217
   PubMed Web of Science ®Google Scholar
• Hakoda M., Kamatani N., Kurumanda S., Kashiwazaki S., Silverman G. J. Involvement of framework region 3 of VH3 IgM in the binding of the B cell superantigen, staphylococcal protein A. Arthritis Rheum. 1995; 38: S190
   PubMedGoogle Scholar
• Silverman G. J., Lucas A. H. Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains. J. Clin. Invest. 1991; 88: 911–920
   PubMedGoogle Scholar
• Hakoda M., Kamatani N., Hayashimoto-Kurumada S., Silverman G. J., Yamanaka H., Terai C., Kashiwazaki S. Differential binding avidities of human IgM for staphylococcal protein A derive from specific germline VH3 gene usage. J. Immunol 1996, in press
   PubMedGoogle Scholar
• Radic M. Z., Mackle J., Erikson J., Mol C, Anderson W. F., Weigert M. Residues that mediate DNA binding of autoimmune antibodies. J. Immunol. 1993; 150: 4966–4977
   PubMed Web of Science ®Google Scholar
• Hong S. C., Waterbury G., Janeway C. A., Jr. Different superantigens interact with distinct sites in the Vβ domain of a single T cell receptor. J. Exp. Med. 1996; 183: 1437–1446
   PubMedGoogle Scholar
• Choi Y., Herman A., DiGustro D., Wade T., Marrack P., Kappler J. Residues of the variable region of the T-cell-receptor β chain that interact with S. aureus toxin superantigens. Nature 1996; 346: 471–473
   Google Scholar
• Pullen A. M., Wade T., Marrack P., Kappler J. W. Identification of the region of T cell receptor beta chain that interacts with the self-superantigen MIs-la. Cell 1990; 61: 1365–1374
   PubMed Web of Science ®Google Scholar
• Pullen A. M., Bill J., Kubo R. T., Marrack P., Kappler J. W. Analysis of the interaction site for the self superantigen Mis-la on T cell receptor V beta. J. Exp. Med. 1991; 173: 1183–1192
   PubMed Web of Science ®Google Scholar
• Cazenave P. A., Marche P. N., Jouvin-Marche E., Voegtle D., Bonhomme F., Bandeira A., Coutinho A. V beta 17 gene polymorphism in wild-derived mouse strains: Two amino acid substitutions in the V beta 17 region greatly alter T cell receptor specificity. Cell 1990; 63: 717–728
   PubMed Web of Science ®Google Scholar
• Pontzer C. H., Irwin M. J., Gascoigne N. R., Johnson H. M. T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc. Natl. Acad. Sci. USA 1992; 89: 7727–7731
   PubMedGoogle Scholar
• White J., Pullen A., Choi K., Marrack P., Kappler J. W. Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J. Exp. Med 1993; 177: 119–125
   PubMed Web of Science ®Google Scholar
• Bentley G. A., Boulot G., Karjalianen K., Mariuzza R. A. Crystal structure of the b chain of a T cell antigen receptor. Science 1995; 267: 1984–1987
   PubMedGoogle Scholar
• Alam S. M., Sim B. C., Gascoigne N. R. Selection of TCR V alpha by MHC class II predicts superantigen reactivity. Int. Immunol. 1995; 7: 1311–1318
   PubMedGoogle Scholar
• Woodland D. L., Smith H. P., Surman S., Le P., Wen R., Blackman M. A. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J. Exp. Med. 1993; 177: 433–442
   PubMed Web of Science ®Google Scholar
• Waanders G. A., Lussow A. R., MacDonald H. R. Skewed T cell receptor V alpha repertoire among superantigen reactive murine T cells. Int. Immunol. 1993; 5: 55–61
   PubMed Web of Science ®Google Scholar
• Vacchio M. S., Kanagawa O., Tomonari K., Hodes R. J. Influence of T cell receptor V alpha expression on Mlsa superantigen-specific T cell responses. J. Exp. Med. 1992; 175: 1405–1408
   PubMed Web of Science ®Google Scholar
• Blackman M. A., Smith H. P., Le P., Woodland D. L. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice. J. Immunol. 1993; 151: 556–565
   PubMedGoogle Scholar
• Labrecque N., Thibodeau J., Mourad W., Sekaly R. P. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J. Exp. Med. 1994; 180: 1921–1929
   PubMed Web of Science ®Google Scholar
• Deckhut A. M., Chien Y., Blackman M. A., Woodland D. L. Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen. J. Exp. Med. 1994; 180: 1931–1935
   PubMed Web of Science ®Google Scholar
• Silverman G. J., Sasano M., Wormsley S. B. Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen. J. Immunol. 1993; 151: 5840–5855
   PubMedGoogle Scholar
• Brezinschek H. P., Brezinschek R. I., Lipsky P. E. Analysis of the heavy chain repertoire of human peripheral B cells using single cell polymerase chain reaction. J. Immunol. 1995; 155: 190
   PubMed Web of Science ®Google Scholar
• Klein U., Kuppers R., Rajewsky K. Variable region gene analysis of B cell subsets derived from a 4-year-old child: Somatically mutated memory B cells accumulate throughout life. J. Exp. Med. 1994; 180: 1383–1393
   PubMedGoogle Scholar
• Klein U., Kuppers R., Rajewsky K. Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur. J. Immunol. 1993; 23: 3272–3277
   PubMed Web of Science ®Google Scholar
• Pascual V., Liu Y. J., Magalski A., De Bouteiller O., Banchereau J., Capra J. D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 1994; 180: 329–339
   PubMed Web of Science ®Google Scholar
• Sjodahl J. Structural studies on the four repetitive Fc-binding regions in protein A from Staphylococcus aureus. Eur. J. Biochem. 1977; 78: 471–479
   PubMedGoogle Scholar
• Lofdahl S., Guss B., Uhlen M., Philipson L., Lindberg M. Gene for staphylococcal protein A. Proc. Natl. Acad. Sci. USA 1983; 80: 697–701
   PubMedGoogle Scholar
• Uhlen M., Guss B., Nilsson B., Gatenbeck S., Philipson L., Lindberg M. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J. Biol. Chetn. 1984; 259: 1695–1702
   PubMed Web of Science ®Google Scholar
• Moks T., Abrahmsen L., Nilsson B., Hellman U., Sjoquist J., Uhlen M. Staphylococcal protein A consists of five IgG-binding domains. Eur. J. Biochem. 1986; 156: 637–643
   PubMedGoogle Scholar
• Deisenhofer J., Jones T. A., Huber R., Sjodahl J., Sjoquist J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-resolution. Hoppe. Seylers. Z. Physiol. Chem. 1978; 359: 975–985
   PubMedGoogle Scholar
• Gouda H., Torigoe H., Saito A., Sato M., Arata Y., Shimada I. Three-dimensional solution structure of the B domain of staphylococcal protein A: Comparisons of the solution and crystal structures. Biochemistry 1992; 31: 9665–9672
   PubMed Web of Science ®Google Scholar
• Inganas M., Johansson S. G., Sjoquist J. Further characterization of the alternative protein-A interaction of immunoglobulins: Demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity. Scand. J. Immunol. 1981; 14: 379–388
   PubMed Web of Science ®Google Scholar
• Erntell M., Myhre E. B., Kronvall G. Non-immune F(ab)2- and Fc-mediated interactions of mammalian immunoglobulins with S. aureus and group C and G streptococci. Acta Pathol. Microbiol. Immunol. Scand. [B]. 1986; 94: 377–385
   PubMedGoogle Scholar
• Ibrahim S. Immunoglobulin binding specificities of the homology regions (domains) of protein A. Scand. J. Immunol. 1993; 38: 368–374
   PubMedGoogle Scholar
• Ljungberg U. K., Jansson B., Niss U., Nilsson R., Sandberg B. E., Nilsson B. The interaction between different domains of staphylococcal protein A and human polyclonal IgG, IgA, IgM and F(ab)2: Separation of affinity from specificity. Mol. Immunol. 1993; 30: 1279–1285
   PubMed Web of Science ®Google Scholar
• Lando P. A., Dohlstein M., Hedlund G., Akerblom E., Kalland T. T cell killing of human colon carcinomas by monoclonal antibody-targeted super-antigens. Cancer Immunol. Immunother. 1993; 36: 223–228
   PubMedGoogle Scholar
• Avery A. C., Markowitz J. S., Grusby M. J., Glimscher L. H., Cantor H. Activation of T cells by superantigen in class II-negative mice. J. Immunol. 1994; 153: 483–491
   Google Scholar
• Bouvet J. P., Pirès R., Lunel-Fabiani F., Crescenzo-Chaigne B., Maillard P., Valla D., Opolon P., Pillot J. Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J. Immunol. 1990; 145: 1176–1180
   PubMedGoogle Scholar
• Bouvet J. P., Pirès R., Charlemagne J., Pillot J., Iscaki S. Non-immune binding of human protein Fv to immunoglobulins from various mammalian and non-mammalian species. Scand. J. Immunol. 1991; 34: 491–496
   PubMedGoogle Scholar
• Ruffet E., Pirès R., Pillot J., Bouvet J. P. Activation of the classical pathway of complement by non-immune complexes of immunoglobulins with human protein Fv (Fv fragment-binding protein). Scand. J. Immunol. 1994; 40: 359–362
   PubMedGoogle Scholar
• Bouvet J. P., Pirés R., Iscaki S., Pillot J. Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions. J. Immunol. 1993; 151: 2562–2571
   PubMed Web of Science ®Google Scholar
• Silverman G. J., Pirés R., Bouvet J. P. An endogenous sialoprotein and a bacterial B-cell superantigen compete in their VH family-specific binding interactions with human immunoglobulins. J. Immunol 1996, in press
   Google Scholar
• Yamada M., Wasserman R., Reichard B. A., Shane S., Caton A. J., Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity. J. Exp. Med. 1991; 173: 395–407
   PubMed Web of Science ®Google Scholar
• Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 1991; 147: 1720–1729
   PubMed Web of Science ®Google Scholar
• Luther S., Shakhov A. N., Xenarios I., Haga S., Imai S., Acha-Orbea H. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB). J. Immunol. 1994; 24: 1757–1764
   Google Scholar
• Sasso E. H., Johnson T., Kipps T. J. Expression of the immunoglobulin VH gene 51 P1 is proportional to its germline gene copy number. J. Clin. Invest. 1996; 97: 2074–2080
   PubMed Web of Science ®Google Scholar
• Pascual V., Capra J. D. B-cell superantigens. Curr. Opin. in Immunol. 1991; 1: 315–317
   Google Scholar
• Childs R., Feizi T. Cross idiotypic specificity among heavy chains of macroglobulins with blood group I and i specificities. Nature 1975; 255: 562–564
   PubMedGoogle Scholar
• Silverman G. J., Carson D. A. Structural characterization of human monoclonal cold agglutinins: Evidence for a distinct primary sequence-defined VH4 idiotype. Eur. J. Immunol. 1990; 20: 351–356
   PubMed Web of Science ®Google Scholar
• Pascual V., Victor K., Lelsz D., Spellerberg M. B., Hamblin T. J., Thompson K. M., Randen I., Natvig J., Capra J. D., Stevenson F. K. Nucleotide sequence analysis of the V regions of two IBM cold agglutinins. Evidence that the VH4–21 gene segment is responsible for the major cross-reactive idiotype. J. Immunol. 1991; 146: 4385–4391
   PubMed Web of Science ®Google Scholar
• Leoni J., Ghiso J., Goni F., Frangione B. The primary structure of the Fab fragment of protein KAU, a monoclonal immunoglobulin M cold agglutinin. J. Biol. Chem. 1991; 266: 2836–2842
   PubMedGoogle Scholar
• Silberstein L. E., Jefferies L. C., Goldman J., Friedman D., Moore J. S., Nowell P. C., Roelcke D., Pruzanski W., Roudier J., Silverman G. J. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991; 78: 2372–2386
   PubMed Web of Science ®Google Scholar
• Pascual V., Victor K., Spellerberg M., Hamblin T. J., Stevenson F. K., Capra J. D. VH restriction among human cold agglutinins. The VH4–21 gene segment is required to encode anti-I and anti-i specificities. J. Immunol. 1992; 149: 2337–2344
   PubMed Web of Science ®Google Scholar
• Stevenson F. K., Smith G. J., North J., Hamblin T. J., Glennie M. J. Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br. J. Haematol. 1989; 72: 9–15
   PubMed Web of Science ®Google Scholar
• Li Y., Spellerberg M. B., Stevenson F. K., Capra J. D., Potter K. N. The I binding specificity of human VH4–34 (VH4–21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J. Mol. Biol. 1996; 256: 577–589
   PubMedGoogle Scholar
• Feeney A. J., Victor K. D., Vu K., Nadel B., Chukwuocha R. U. Influence of the V(D)J recombination mechanism on the formation of the primary T and B cell repertoires. Semin. Immunol. 1994; 6: 155–163
   PubMedGoogle Scholar
• Gu H., Tarlington D., Muller W., Rajewsky K., Forster L. Most peripheral B cells in mice are ligand selected. J. Exp. Med. 1991; 173: 1357–1371
   PubMedGoogle Scholar
• Pennell C. A., Sheehan K. M., Brodeur P. H., Clarke S. H. Organization and expression of VH gene families preferentially expressed by Ly-1+ (CD5) B cells. Eur. J. Immunol. 1989; 19: 2115–2121
   PubMedGoogle Scholar
• Ye J., McCray S. K., Clarke S. H. The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. EMBOJ. 1996; 15: 1524–1533
   PubMedGoogle Scholar
• Kozlowski L., Lambris J. D., Silverman G. J., Levinson A. Complement activation by a B cell superantigen. J. Immunol. 1996; 157: 1200–1206
   PubMedGoogle Scholar
• Silverman G. J. Unconventional B-cell antigens and human immune repertoires. Ann. N. Y. Acad. Sci. 1995; 764: 566–585
   Google Scholar
• Silverman G. J. B-cell superantigens and the somatic diversification of immune repertoires: Molecular and cellular implications. Human B-cell superantigens, M. Zouali. Landes Co., Austin, TX 1996, in press
   Google Scholar
• Fearon D. T., Carter R. H. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural and acquired immunity. Annu. Rev. Immunol. 1995; 13: 127–149
   PubMed Web of Science ®Google Scholar